What did Algorae Pharmaceuticals (ASX:1AI) secure with NSW Health?

Algorae Pharmaceuticals (ASX:1AI) secured a public hospital supply contract with NSW Health following a competitive tender process. The agreement has an initial term of three years, with two optional one-year extension periods.

What are the financial details of the agreement for Algorae Pharmaceuticals (ASX:1AI)?

Algorae Pharmaceuticals (ASX:1AI) stated that the specific pricing, scope, and volumes of the agreement are confidential under the contract terms. Consequently, the company is currently unable to quantify the exact financial impact or revenue details of the award.

When will the contract rollout begin for Algorae Pharmaceuticals (ASX:1AI)?

The onboarding and rollout process is already underway for Algorae Pharmaceuticals (ASX:1AI). The company expects its first supply under the contract to occur in the fourth quarter of 2026.

How did the stock market react to the announcement from Algorae Pharmaceuticals (ASX:1AI)?

The Algorae Pharmaceuticals (ASX:1AI) share price rose to $0.013 following the public announcement of the contract award.

What does this contract mean for the commercial strategy of Algorae Pharmaceuticals (ASX:1AI)?

Algorae Pharmaceuticals (ASX:1AI) stated that the contract provides access to one of Australia's largest public healthcare procurement networks. The company expects this milestone to validate its commercial capabilities and support its ongoing growth strategy.

Image for illustrative purposes only. Not a real photo.

Algorae wins NSW Health public hospital contract

Written by Isaac FrancisPublished Jul 1, 2026, 7:02 AM

Algorae Pharmaceuticals has been awarded a public hospital supply contract by NSW Health after a competitive tender process.
The company's share price rose to $0.013 following the announcement of the three-year agreement.
The contract supports the company's commercial strategy and provides access to a large public healthcare procurement network.

Algorae Pharmaceuticals (ASX:1AI) has secured a three-year public hospital supply contract with NSW Health to expand its commercial distribution network.

This agreement follows a commercial pattern after a licensing deal was executed with Torrent Pharma in May.

:Securing a place on a NSW Health supply contract is a major milestone for AlgoraeRx," said AlgoraeRx Managing Director and Chief Commercial Officer Vishal Shah.

Onboarding is underway, with the first supply expected in Q4 while pricing remains confidential.

Following the announcement, the Algorae Pharmaceuticals share price was up at $0.013.

The company utilises its proprietary artificial intelligence platform, AlgoraeOS, to accelerate drug discovery alongside its commercial division.

Previously in 2026, the company partnered with the Peter MacCallum Cancer Centre and raised $3.9 million.

Algorae wins NSW Health public hospital contract

Frequently asked questions

Assets related to this article